Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
130M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
30.1M
-
Shares change
-
+5.17M
-
Total reported value, excl. options
-
$337M
-
Value change
-
+$57.8M
-
Put/Call ratio
-
0.08
-
Number of buys
-
45
-
Number of sells
-
-9
-
Price
-
$11.19
Significant Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q2 2023
63 filings reported holding PROK - PROKIDNEY CORP. - Ordinary Shares as of Q2 2023.
PROKIDNEY CORP. - Ordinary Shares (PROK) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.1M shares
of 130M outstanding shares and own 23.2% of the company stock.
Largest 10 shareholders include Social Capital Group LLC (13.3M shares), BlackRock Inc. (3.32M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.19M shares), VANGUARD GROUP INC (3.06M shares), Bleichroeder LP (2M shares), Brown University (1M shares), STATE STREET CORP (990K shares), GEODE CAPITAL MANAGEMENT, LLC (761K shares), NORTHERN TRUST CORP (452K shares), and BANK OF AMERICA CORP /DE/ (410K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.